Lawrence Mehren
Net Worth
Last updated:
What is Lawrence Mehren net worth?
The estimated net worth of Mr. Lawrence Mehren is at least $16,439,739 as of 17 Aug 2017. He owns shares worth $25,921 as insider, has earned $12,601,308 from insider trading and has received compensation worth at least $3,812,510 in Accelerate Diagnostics, Inc..
What is the salary of Lawrence Mehren?
Mr. Lawrence Mehren salary is $293,270 per year as Advisor in Accelerate Diagnostics, Inc..
How old is Lawrence Mehren?
Mr. Lawrence Mehren is 59 years old, born in 1966.
What stocks does Lawrence Mehren currently own?
As insider, Mr. Lawrence Mehren owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Accelerate Diagnostics, Inc. (AXDX) | Advisor | 762,381 | $0.03 | $25,921 |
What does Accelerate Diagnostics, Inc. do?
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.
Lawrence Mehren insider trading
Accelerate Diagnostics, Inc.
Mr. Lawrence Mehren has made 2 insider trades between 2012-2017, according to the Form 4 filled with the SEC. Most recently he sold 223,215 units of AXDX stock worth $5,000,016 on 17 Aug 2017.
The largest trade he's ever made was exercising 14,000,000 units of AXDX stock on 26 Jun 2012. As of 17 Aug 2017 he still owns at least 762,381 units of AXDX stock.
Accelerate Diagnostics key executives
Accelerate Diagnostics, Inc. executives and other stock owners filed with the SEC:
- Mr. Jack Phillips (59) Chief Executive Officer, Pres & Director
- Mr. Lawrence Mehren (59) Advisor
- Mr. Ron Price (61) Chief Commercial Officer of Americas
- Mr. Steve Reichling (47) Chief Financial Officer, Chief Accounting Officer & Sec.